Literature DB >> 7791160

Limitations of invasive modalities in the diagnosis of primary angiitis of the central nervous system.

G F Duna1, L H Calabrese.   

Abstract

OBJECTIVE: Rheumatologists are often consulted to evaluate patients suspected of having primary angiitis of the central nervous system (PACNS). The diagnostic process relies heavily on interpreting the results of cerebral angiography and brain biopsy. We have assessed the operating characteristics of those invasive modalities in the diagnosis of PACNS:
METHODS: The records of 30 consecutive patients referred for the evaluation of possible PACNS were retrospectively analyzed. Patients were evaluated on clinical grounds, and the diagnostic process was extended accordingly until a reasonable probability of a definable disease was present. All patients had cerebral angiography and/or brain biopsy. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were assessed for each of the following diagnostic tests: cerebral angiography, brain biopsy, cerebrospinal fluid (CSF) examination, and magnetic resonance imaging (MRI).
RESULTS: The final diagnostic outcomes were: PACNS in 7, lymphoproliferative disease in 4, infection in 4, demyelinating disease in 2, reversible vasospastic disorder in 6, and a variety of other nonvasculitic conditions in 7. Cerebral angiography had less than 30% specificity and PPV for PACNS: Brain biopsy had limited sensitivity and NPV (53% and 70%, respectively). CSF examination and MRI, although sensitive, lacked specificity.
CONCLUSION: In patients suspected of having PACNS, the results of invasive diagnostic modalities should be interpreted with caution. Accurate diagnosis should rarely rely on any single study and should only follow careful clinical, radiographic and pathologic correlation.

Entities:  

Mesh:

Year:  1995        PMID: 7791160

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  42 in total

Review 1.  A differential diagnosis of central nervous system demyelination: beyond multiple sclerosis.

Authors:  Christopher Eckstein; Shiv Saidha; Michael Levy
Journal:  J Neurol       Date:  2011-09-20       Impact factor: 4.849

2.  Varicella-zoster vasculitis presenting with intracranial hemorrhage.

Authors:  Rajan Jain; John Deveikis; Susan Hickenbottom; Suresh K Mukherji
Journal:  AJNR Am J Neuroradiol       Date:  2003-05       Impact factor: 3.825

Review 3.  [Cerebral vasculitis].

Authors:  P Berlit
Journal:  Nervenarzt       Date:  2004-08       Impact factor: 1.214

Review 4.  [Primary central nervous system vasculitis].

Authors:  S Schuster; T Magnus
Journal:  Z Rheumatol       Date:  2015-12       Impact factor: 1.372

Review 5.  MR angiography of the intracranial vessels: technical aspects and clinical applications.

Authors:  Ozkan Ozsarlak; Johan W Van Goethem; Menno Maes; Paul M Parizel
Journal:  Neuroradiology       Date:  2004-12-04       Impact factor: 2.804

6.  MR imaging and angiography of primary CNS vasculitis of childhood.

Authors:  R I Aviv; S M Benseler; E D Silverman; P N Tyrrell; G Deveber; L M Tsang; D Armstrong
Journal:  AJNR Am J Neuroradiol       Date:  2006-01       Impact factor: 3.825

7.  The diagnostic contribution of intracranial vessel wall imaging in the differentiation of primary angiitis of the central nervous system from other intracranial vasculopathies.

Authors:  Ahmet Kursat Karaman; Bora Korkmazer; Serdar Arslan; Ugur Uygunoglu; Ercan Karaarslan; Osman Kızılkılıc; Naci Kocer; Civan Islak
Journal:  Neuroradiology       Date:  2021-03-08       Impact factor: 2.804

Review 8.  Updates in ANCA-associated vasculitis.

Authors:  Christian Pagnoux
Journal:  Eur J Rheumatol       Date:  2016-01-29

9.  Primary Central Nervous System Vasculitis Mimicking a Cortical Brain Tumor: A Case Report.

Authors:  Joo-Seok Lee; Tae-Young Jung; Kyung-Hwa Lee; Seul-Kee Kim
Journal:  Brain Tumor Res Treat       Date:  2017-04-30

10.  Central nervous system angiitis: a series of 31 patients.

Authors:  Guillaume Geri; David Saadoun; Rémy Guillevin; Sophie Crozier; Catherine Lubetzki; Karima Mokhtari; Zahir Amoura; Bertrand Wechsler; Du Le Boutin; Nathalie Costedoat-Chalumeau; Yves Samson; Patrice Cacoub
Journal:  Clin Rheumatol       Date:  2013-10-06       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.